Patent · US Active

N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists

US11731974B2 · kind B2 · utility

0Cited by

12References

8Claims

0Family size

Assignee

Ogeda SA · BE

Inventors

Hamid R. Hoveyda · Brussels, BE
Guillaume Dutheuil · Vedrin, BE
Graeme L. Fraser · Bousval, BE

Key dates

Filing date	Oct 8, 2020
Grant date	Aug 22, 2023
Priority date	—
Expiry date	Aug 6, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A method for treating and/or preventing polycystic ovary syndrome (PCOS) including the administration, to a patient in need thereof, of a pharmaceutically effective amount of a compound of Formula I or a pharmaceutically acceptable solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.